Rekombinanter CD138 (Indatuximab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter CD138 (Indatuximab Biosimilar) Antikörper (ABIN6964427)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Verwendungszweck
- Anti-CD138 (indatuximab biosimilar) mAb
-
Produktmerkmale
- BT-062, BT062, nBT062-DM4
-
Aufreinigung
- Purified from cell culture supernatant by affinity chromatography
-
Isotyp
- IgG4
-
-
-
-
Applikationshinweise
- Flow Cyt 1:100
-
Kommentare
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with deionized water
-
Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
Haltbarkeit
- 12 months
-
-
- CD138 (Indatuximab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
- Synonyms: SDC1, Syndecan-1, CD138, SYND1, SDC
-
UniProt
- P18827
Target
-